Share on StockTwits
 

CRYO-CELL International (NASDAQ:CCEL) CEO David Portnoy acquired 21,880 shares of the stock in a transaction dated Tuesday, February 4th. The shares were purchased at an average price of $1.96 per share, with a total value of $42,884.80. Following the completion of the transaction, the chief executive officer now directly owns 20,893 shares of the company’s stock, valued at approximately $40,950. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of CRYO-CELL International (NASDAQ:CCEL) remained flat at $1.95 during trading on Wednesday. 2,348 shares of the company’s stock traded hands. CRYO-CELL International has a 52 week low of $1.80 and a 52 week high of $2.30. The stock has a 50-day moving average of $1.92 and a 200-day moving average of $1.99. The company’s market cap is $20.7 million.

Cryo-Cell International, Inc (NASDAQ:CCEL) is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.